Health
Surgery wait times for cancer, joint replacement patients still lagging amid backlog

A surgery is performed in the operating room at Toronto’s Hospital for Sick Children on Wednesday, November 30, 2022. THE CANADIAN PRESS/Chris Young
By Nicole Ireland
Hospitals across Canada are performing surgeries at close to pre-pandemic levels, but many patients continue to face longer-than-recommended wait times due to the backlog created by COVID-19, a new report from the Canadian Institute for Health Information says.
The report, published on Thursday, looked at knee and hip replacements, cataract surgeries and cancer surgeries performed in 2019 versus those performed in 2022.
Thousands of joint replacement and cataract surgeries were cancelled or delayed when COVID-19 hit.
“Things like knee and hip replacements and cataracts are what we call scheduled surgeries and they were particularly affected during the pandemic because they’re not life-threatening,” said Tracy Johnson, director of health system analytics at CIHI.
“They are very uncomfortable for patients. They cause them more pain. They might even have economic pain. But those are the kinds of things that had to be delayed, especially in the first part of the pandemic when we didn’t know what kind of COVID stuff was going to come at us,” Johnson said.
Those delays created a backlog of surgical procedures that health-care providers still haven’t been able to catch up on.
“The most recent data shows that while the monthly number of scheduled surgeries is nearing pre-pandemic levels, this is insufficient to clear the backlog and improve wait times,” the CIHI report said.
“It also shows that catching up has been more challenging for joint replacement surgeries, which are primarily performed in hospital operating rooms, than for cataract surgeries, which can be done in day procedure rooms or community clinics.”
The longest recommended wait time for knee and hip replacements is six months.
Only half of Canadian patients got their knee replacement surgery within that time frame between April and September 2022, the researchers found. Prior to the pandemic, about 70 per cent of knee replacements were done within the recommended period.
About 57 per cent of hip replacement patients had their surgery in the recommended six-month window in 2022 compared to 75 per cent of patients in 2019.
Cancer surgery wait times haven’t been as dramatically affected because the most urgent cases were prioritized during COVID-19 shutdowns, said Johnson.
Still, during the first several months of the pandemic, there were about 20 per cent fewer cancer procedures performed than before. Those delays and cancellations created the initial backlog, the report said.
Half of patients needing breast, bladder, colorectal and lung cancer surgery waited one to three days longer between April and September 2022 compared to before the pandemic, it said. For patients with prostate cancer, that average wait time jumped to 12 days longer.
Andrea Seale, CEO of the Canadian Cancer Society, said it’s critical for the health-care system to reduce those wait times.
“A day or two might not sound like a lot but it truly is when it comes to cancer because it’s just a disease that cannot wait,” she said.
In a survey of 700 patients and caregivers conducted by the Canadian Cancer Society in November, about a quarter of respondents reported they are still experiencing cancelled or postponed appointments, Seale said.
“Any delay is extremely distressing to people who are facing cancer.”
For cataract surgery, the recommended maximum wait time is 112 days. Although two-thirds of Canadian patients, on average, are getting their surgery within that time frame — the same proportion as before the pandemic — there is “considerable variation” across the provinces, the CIHI report said.
More patients in Newfoundland and Labrador, Quebec and Ontario are waiting longer for cataract surgery, while a higher proportion of patients in B.C., Alberta, Manitoba and P.E.I. are getting their cataract procedures within the recommended 112 days.
Dr. Thomas Forbes, surgeon-in-chief at University Health Network in Toronto, said the CIHI report is “valuable” as it highlights patients most affected by surgical backlogs.
“It is really an all-hands-on-deck effort at our hospital and at, I suspect, all other hospitals,” he said.
Forbes agreed with the report’s findings that hospitals have to do even more surgeries than they did before the pandemic to catch up, noting that an aging population increases the demand even more.
UHN has expanded its operating room capacity between 110 and 120 per cent compared to before the pandemic, he said.
That means extending operating room hours during the week, as well as scheduling surgeries on weekends, which had previously been limited to emergencies only.
UHN has also reopened old operating rooms that had been decommissioned, Forbes said.
“Everything is on the table,” he said, including the possibility of transferring patients to a different physician who has a shorter waiting list.
The current staffing shortage, particularly among nurses, is another issue that has to be resolved for hospitals to be able to catch up, Johnson from CIHI said.
“You have a list of people who need surgeries, but you also need people to be able to either perform the surgeries or care for those people post-op,” she said.
This report by The Canadian Press was first published March 23, 2023.
Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.
Health
Health Foundation commits $325,000 to support child, adolescent mental health

Foundation donors provide furnishings, supplies for program for ages 13 to 17
Thanks to Central Alberta donors, the Red Deer Regional Health Foundation is supporting Step Up Step Down, a program helping youth aged 13 to 17 who have complex mental health challenges.
Step-Up Step-Down will find a new home in the Centre of Excellence, described as a centre for “healing, recovery, and prevention” being built at Red Deer Polytechnic.
“We thank our generous donors for supporting the Foundation’s greatest needs, which allows us to dedicate funds to help young people and families in our community,” says Manon Therriault, Chief Executive Officer of the Red Deer Regional Health Foundation.
Funds raised by the Foundation will provide a fully furnished, equipped and supplied environment to allow staff to provide timely recreational, therapeutic, and extracurricular activities to the youth in care. Funded items include furnishings, equipment, and supplies for the kitchen, bedrooms, sensory and therapy rooms, classroom, living room, gym, outdoor spaces, and indoor activity spaces.
The move into the Centre of Excellence will allow expansion of the Step Up Step Down program up to 16 beds from the current 5 beds and allow the program to provide intensive, comprehensive, individualized clinical services to youth in a live-in and community setting.
Step Up Step Down will support approximately 50-75 live-in treatment families, along with 100 intensive outpatient families per year, reducing stress on the Emergency Department and Pediatric Psychiatric units at the Red Deer Hospital. The facility will serve youth and families from all areas of the Central Zone.
About Red Deer Regional Health Foundation
The Red Deer Regional Health Foundation is a fundraising organization for Alberta Health Services Central Zone, with a mandate to raise and disburse funds for programs, services, and the purchase of medical equipment.
Addictions
Ruling clears way for Purdue Pharma to settle opioid claims, protect Sacklers from lawsuits

Jayde Newton helps to set up cardboard gravestones with the names of victims of opioid abuse outside the courthouse where the Purdue Pharma bankruptcy is taking place in White Plains, N.Y., on Aug. 9, 2021. A three-judge panel of the 2nd U.S. Circuit Court of Appeals in New York on Tuesday, May 30 overturned a lower court’s 2021 ruling that found bankruptcy courts did not have the authority to protect members of the Sackler family who own the company and who have not filed for bankruptcy protection from lawsuits. (AP Photo/Seth Wenig, File)
By Geoff Mulvihill
A federal court ruling cleared the way Tuesday for OxyContin maker Purdue Pharma’s settlement of thousands of legal claims over the toll of opioids.
Under the plan approved by the 2nd U.S. Circuit Court of Appeals in New York, members of the wealthy Sackler family would give up ownership of Stamford, Connecticut-based Purdue, which would become a new company known as Knoa, with its profits being used to fight the opioid crisis. They would also contribute $5.5 billion to $6 billion in cash over time. A chunk of that money — at least $750 million — is to go to individual victims of the opioid crisis and their survivors. Only one other major opioid lawsuit settlement includes payments for victims.
Tuesday’s decision also protects members of the Sackler family from lawsuits over the toll of opioids, even though they did not file for bankruptcy.
The court’s ruling reversed a 2021 ruling that found bankruptcy court judges did not have the authority to approve a settlement that would offer bankruptcy protections for those who have not filed for bankruptcy.
Those protections are at the heart of the proposed deal that would end claims against Purdue filed by thousands of state, local and Native American tribal governments and other entities.
“It’s a great day for victims, some of who desperately need the money and have been waiting for this day for a long time,” said Ed Neiger, a lawyer representing individual victims.
Sackler family members have been clear: If they don’t get the legal protections, they won’t do their part of the deal.
“The Sackler families believe the long-awaited implementation of this resolution is critical to providing substantial resources for people and communities in need,” family members who own Purdue said in a statement Tuesday. “We are pleased with the Court’s decision to allow the agreement to move forward and look forward to it taking effect as soon as possible.”
Purdue issued its own statement, calling the ruling “a victory for Purdue’s creditors, including the states, local governments, and victims who overwhelmingly support the Plan of Reorganization.” The company said it would focus on delivering “billions of dollars of value for victim compensation, opioid crisis abatement, and overdose rescue medicines.”
Several states had been withholding support for the plan, but after a new round of negotiations last year, all of them came on board. That left just one high-profile objector: the Office of the U.S. Bankruptcy Trustee, an arm of the Justice Department.
A lawyer from that office told the 2nd Circuit in April 2022 that it’s a “fundamental inconsistency” that people who do not seek bankruptcy protection and have to give up most of their assets could be exempted from some lawsuits.
The Justice Department has not immediately said whether it would appeal Tuesday’s ruling to the U.S. Supreme Court. A spokesperson declined comment Tuesday.
The the latest version of the settlement must still be approved by a bankruptcy court judge before it can be finalized.
While Sackler family members still technically own Purdue, they stopped receiving money from the company years ago.
All three federal appeals judges who heard the Purdue case last year agreed that the Sackler family can be protected from lawsuits. But one — Richard Wesley — said in a separate opinion that he did so reluctantly, noting that while courts allow such deals they’re not explicitly allowed under bankruptcy law.
Purdue is perhaps the highest-profile player in the opioid industry. But several other drugmakers, distribution companies and pharmacies also have been sued by state and local governments. While a handful of cases have gone to trial, many also are being settled.
The total value of proposed and finalized settlements in recent years is more than $50 billion. Companies that have reached deals include drugmakers Johnson & Johnson and Teva; distribution giants AmerisourceBergen, Cardinal Health and McKesson; and pharmacy chains CVS, Walgreens and Walmart. Most of the money is required to be used to fight the opioid crisis, which has been linked to more than 500,000 deaths in the U.S. over the past two decades, including more than 70,000 a year recently.
In recent years, most of the deaths have been connected to fentanyl and other illicit synthetic opioids, not prescription painkillers.
-
Agriculture2 days ago
Canada saw decline in fresh fruit, vegetable availability in 2022: StatCan
-
Health2 days ago
Health Foundation commits $325,000 to support child, adolescent mental health
-
Disaster2 days ago
One adult, 16 children injured in fall during school trip to Winnipeg historic site
-
Business24 hours ago
Peavey Industries LP, the Red Deer-based retailer, has announced the acquisition of long-term partner and fellow Red Deer stalwart, Guy’s Freightways.
-
armed conflict2 days ago
Court of Appeal overturns ruling directing Ottawa to help repatriate men in Syria
-
International2 days ago
David Johnston plans to keep role, as House of Commons votes for him to step aside
-
National1 day ago
Firefighters from U.S., South Africa to battle Canada’s ‘unprecedented’ fires
-
Social Media2 days ago
Meta starts testing paid verification for Canadian Facebook, Instagram creators